AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹3,266 Cr | ₹2,739 Cr | ₹4,496 Cr | ₹2,938 Cr | ₹2,429 Cr |
What is the latest Capital Work in Progress ratio of AUROBINDO PHARMA ?
Year | Capital Work in Progress |
---|---|
Mar2025 | ₹3,266 Cr |
Mar2024 | ₹2,739 Cr |
Mar2023 | ₹4,496 Cr |
Mar2022 | ₹2,938 Cr |
Mar2021 | ₹2,429 Cr |
How is Capital Work in Progress of AUROBINDO PHARMA Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2025 | ₹3,266 Cr | 19.22 | |
Mar2024 | ₹2,739 Cr | -39.08 | |
Mar2023 | ₹4,496 Cr | 53.07 | |
Mar2022 | ₹2,938 Cr | 20.94 | |
Mar2021 | ₹2,429 Cr | - |
Compare Capital Work in Progress of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹63,574.4 Cr | 5.2% | 3.5% | -26.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹127,124.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 5.2% |
3.5% |
-26.9% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses